-
Time-Dependent Effects of Early-Onset Epstein-Barr Viremia on Adult Acute Leukemia Patients Following Allo-HSCT with ATG-Containing MAC Regimen
In July 2021, a study led by Professor Zhengzheng Fu from the First Affiliated Hospital of Soochow University was published in the international academic journal ——Annals of Hematology. The title…
-
ASCO-GU Interview | Dr. Yige Bao Shares Progress in PARPi Precision Treatment of Prostate Cancer and His Team’s Research on Neoadjuvant Therapy for UTUC
Oncology Frontier: Can you share with us the research your team submitted to this ASCO-GU meeting? Dr. Yige Bao: At this ASCO-GU meeting, I represented the urology team led by…
-
Imatinib compared with second-generation tyrosine kinase inhibitors in persons with chronic myeloid leukemia presenting in accelerated phase
In July 2023, a study led by Professor Qian Jiang from Peking University Institute of Hematology was published in the international academic journal ——American Journal of Hematology (IF=12.8). The title…
-
External Validation of Predictive Scoring Systems for Molecular Responses in Chronic Myeloid Leukemia Receiving Imatinib Therapy
In September 2023, a study led by Professor Qian Jiang from Peking University Institute of Hematology was published in the international academic journal ——Leukemia(IF=11.4). The title of the study is…
-
Daratumumab-based immunotherapy vs. lenalidomide, bortezomib and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: a systemic review
In January 2024, a study led by Professor Ting Niu from West China Hospital, Sichuan University was published in the international academic journal ——Frontiers In Oncology. The title of the…
-
Ectopic expression of transcription factor ONECUT3 drives complex karyotype in Myelodysplastic Syndromes
In February 2024, a study led by Professor Hongyan Tong from the First Affiliated Hospital, Zhejiang University School of Medicine was published in the international academic journal ——Journal of Clinical…
-
Consolidation Therapy for Acute Myeloid Leukemia in Older Patients: A Study on the Efficacy of Decitabine and Intermediate-Dose Cytarabine
Consolidation Therapy for Acute Myeloid Leukemia in Older Patients: A Study on the Efficacy of Decitabine and Intermediate-Dose Cytarabine
-
Annual Review | Professor Hui Wei: Progress in Clinical Diagnosis and Treatment of Acute Myeloid Leukemia (AML)
With ardent vigor and unwavering dedication, the past year has seen significant advances in the field of hematologic oncology, driven by the rapid development of innovative therapies and cutting-edge technologies. The application of novel molecular biology techniques has not only refined the prognostic stratification of Acute Myeloid Leukemia (AML) but has also fostered more precise…
Connecting Medical Expertise through Media